Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
RPE65	6121	broad.mit.edu	37	1	68904666	68904666	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr1:68904666T>A	ENST00000262340.5	-	9	1010	c.957A>T	c.(955-957)gaA>gaT	p.E319D		NM_000329.2	NP_000320.1	Q16518	RPE65_HUMAN	retinal pigment epithelium-specific protein 65kDa	319		NA		NA	visual perception	cytoplasm|plasma membrane	all-trans-retinyl-palmitate hydrolase activity|metal ion binding|retinol isomerase activity		NA	central_nervous_system(1)|kidney(3)|large_intestine(12)|lung(15)|ovary(1)|prostate(2)|upper_aerodigestive_tract(1)	35						ACCCATTGTCTTCATAGGTGT	0.413	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						269	265	266	NA		NA	NA	1		NA											NA				68904666		2203	4300	6503	SO:0001583	missense			ENSG00000116745	HGNC:10294	NM_000329	Approved	uc001dei.1	NA	Q5T9U3	ENST00000262340.5	37	CCDS643.1	.	.	.	.	.	.	.	.	.	.	T	18.08	3.543259	0.65198	.	.	ENSG00000116745	ENST00000262340	D	0.97016	-4.21	4.87	3.74	0.42951	.	0.000000	0.85682	D	0.000000	D	0.97182	0.9079	M	0.86268	2.805	0.58432	D	0.999999	D	0.67145	0.996	D	0.75484	0.986	D	0.96823	0.9605	10	0.72032	D	0.01	-1.338	8.3694	0.32406	0.0:0.1756:0.0:0.8244	.	319	Q16518	RPE65_HUMAN	D	319	ENSP00000262340:E319D	ENSP00000262340:E319D	E	-	3	2	RPE65	68677254	1	0.71417	0.996	0.52242	0.949	0.60115	0.916	0.28651	0.719	0.32188	-0.263	0.10527	GAA	RPE65-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000025509.1	-10.304992	KEEP		-	53.266145	0.073529	25	315	---	---	---	---	1	0.671306	2	28	0	281	27	334	0	281	2	0	0	0	0	0	0	27	334	0	281	2	TP
COL5A2	1290	broad.mit.edu	37	2	189918184	189918184	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr2:189918184C>T	ENST00000374866.3	-	38	2793	c.2519G>A	c.(2518-2520)gGg>gAg	p.G840E		NM_000393.3	NP_000384.2	P05997	CO5A2_HUMAN	collagen, type V, alpha 2	840		NA		NA	axon guidance|collagen fibril organization|eye morphogenesis|skin development	collagen type V	extracellular matrix structural constituent		NA	NS(3)|breast(2)|central_nervous_system(1)|endometrium(2)|kidney(4)|large_intestine(16)|lung(53)|ovary(3)|prostate(2)|skin(6)|urinary_tract(3)	95			OV - Ovarian serous cystadenocarcinoma(117;0.0106)|Epithelial(96;0.127)			TCCAGTTGGCCCATTTTCACC	0.343	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						55	57	57	NA		NA	NA	2		NA											NA				189918184		2203	4300	6503	SO:0001583	missense			ENSG00000204262	HGNC:2210	NM_000393	Approved	uc002uqk.3	NA	P78440|Q13908|Q53WR4|Q59GR4|Q6LDJ5|Q7KZ55|Q86XF6|Q96QB0|Q96QB3	ENST00000374866.3	37	CCDS33350.1	.	.	.	.	.	.	.	.	.	.	C	21.4	4.142671	0.77888	.	.	ENSG00000204262	ENST00000374866;ENST00000452536	D	0.99619	-6.28	5.86	5.86	0.9398	.	0.000000	0.56097	D	0.000040	D	0.99857	0.9933	H	0.99286	4.5	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.97110	0.999;1.0	D	0.96597	0.9442	9	.	.	.	.	20.1951	0.98241	0.0:1.0:0.0:0.0	.	480;840	Q5PR22;P05997	.;CO5A2_HUMAN	E	840;480	ENSP00000364000:G840E	.	G	-	2	0	COL5A2	189626429	1	0.71417	1	0.80357	0.944	0.59088	7.449	0.80643	2.78	0.9567	0.585	0.79938	GGG	COL5A2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000313523.1	61.241647	KEEP		-	64.713255	0.278481	22	57	---	---	---	---	1	0.9999716	20	26	0	108	26	61	0	108	2	0	0	0	0	0	0	26	61	0	108	2	TP
KIF9	64147	broad.mit.edu	37	3	47307239	47307239	+	Silent	SNP	G	G	A	rs146278510		GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr3:47307239G>A	ENST00000335044.2	-	8	1254	c.897C>T	c.(895-897)caC>caT	p.H299H	KIF9_ENST00000352910.4_Silent_p.H206H|KIF9_ENST00000487440.1_5'UTR|KIF9_ENST00000265529.3_Silent_p.H299H|KIF9_ENST00000444589.2_Silent_p.H299H|KIF9_ENST00000452770.2_Silent_p.H299H	NM_001134878.1|NM_182902.3	NP_001128350.1|NP_878905.2	Q9HAQ2	KIF9_HUMAN	kinesin family member 9	299		NA		NA	blood coagulation|microtubule-based movement	cytoplasm|microtubule	ATP binding|microtubule motor activity		NA	central_nervous_system(1)|endometrium(2)|large_intestine(8)|lung(15)|skin(4)|stomach(2)|upper_aerodigestive_tract(2)	34		Acute lymphoblastic leukemia(5;0.164)		BRCA - Breast invasive adenocarcinoma(193;0.000284)|KIRC - Kidney renal clear cell carcinoma(197;0.00609)|Kidney(197;0.007)		CCTTCAGAGCGTGGGTGAGCT	0.582	NA	NA	NA			NA	NA	NA		NA	NA	NA	G	2	9e-04	NA	0.01	2184	NA	0.9996	,	,	NA	3e-04	NA	NA	NA	0.0011	0.8824	LOWCOV,EXOME	NA	NA	4e-04	SNP	Colon(44;962 1147 15977 24541)	NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA	G	,,	0,4406		0,0,2203	179	137	152	NA	897,897,897	-4.9	0.9	3	dbSNP_134	152	1,8599	1.2+/-3.3	0,1,4299	yes	coding-synonymous,coding-synonymous,coding-synonymous	KIF9	NM_001134878.1,NM_022342.4,NM_182902.3	,,	0,1,6502	AA,AG,GG	NA	0.0116,0.0,0.0077	,,	299/791,299/726,299/791	47307239	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000088727	HGNC:16666		Approved	uc003cqx.3	NA	Q86Z28|Q9H8A4	ENST00000335044.2	37	CCDS2752.1												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		KIF9-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		70.066873	KEEP		-	85.966836	0.188571	33	142	---	---	---	---	1	0.7986886	4	11	0	144	35	152	0	144	2	0	0	0	0	0	0	35	152	0	144	2	TP
RP9	6100	broad.mit.edu	37	7	33138995	33138995	+	Silent	SNP	G	G	A			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr7:33138995G>A	ENST00000297157.3	-	3	254	c.237C>T	c.(235-237)caC>caT	p.H79H		NM_203288.1	NP_976033.1	Q8TA86	RP9_HUMAN	retinitis pigmentosa 9 (autosomal dominant)	79	PIM1-binding (By similarity).	NA		NA	RNA splicing	nucleus	nucleic acid binding|protein binding|zinc ion binding		NA	large_intestine(3)|lung(3)|urinary_tract(1)	7			GBM - Glioblastoma multiforme(11;0.0403)			ATTCCCTGGCGTGTTCATTGC	0.463	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						175	155	162	NA		NA	NA	7		NA											NA				33138995		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000164610	HGNC:10288	NM_203288	Approved	uc003tdm.3	NA		ENST00000297157.3	37	CCDS5440.1												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		RP9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000328914.1	81.232615	KEEP		-	119.502358	0.150307	49	277	---	---	---	---	1	0.9999999	31	118	0	151	51	298	0	151	2	0	0	0	0	0	0	51	298	0	151	2	TP
RNU6-389P	0	broad.mit.edu	37	7	55752973	55752973	+	RNA	SNP	C	C	T			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr7:55752973C>T	ENST00000517048.1	+	0	0				FKBP9L_ENST00000455909.1_RNA						NA		NA		NA					NA		NA						GGCCAGCCACCAGCTCCAGCA	0.562	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						150	127	134	NA		NA	NA	7		NA											NA				55752973		692	1591	2283										NA		ENST00000517048.1	37													NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		RNU6-389P-201	KNOWN	basic	snRNA	NA	snRNA		43.130046	KEEP		+	49.045639	0.21519	17	62	---	---	---	---	1	0.5364279	5	2	0	40	23	73	0	40	2	0	0	0	0	0	0	23	73	0	40	2	TP
CCDC146	57639	broad.mit.edu	37	7	76796979	76796979	+	5'UTR	SNP	G	G	A			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr7:76796979G>A	ENST00000285871.4	+	0	121				CCDC146_ENST00000431197.1_5'UTR|RP11-467H10.2_ENST00000459742.1_RNA	NM_020879.2	NP_065930.2	Q8IYE0	CC146_HUMAN	coiled-coil domain containing 146	NA		NA		NA					NA	breast(3)|central_nervous_system(3)|endometrium(1)|kidney(4)|large_intestine(7)|lung(10)|ovary(1)|pancreas(1)|prostate(1)|skin(1)|stomach(2)	34		all_cancers(73;0.128)|all_lung(88;0.0986)|all_epithelial(88;0.163)|Myeloproliferative disorder(862;0.205)				TTTTAGAATCGTGAAAAATGG	0.308	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						35	35	35	NA		NA	NA	7		NA											NA				76796979		2203	4299	6502	SO:0001623	5_prime_UTR_variant			ENSG00000135205	HGNC:29296	NM_020879	Approved	uc003uga.3	NA	A8K8X6|Q9P223	ENST00000285871.4	37	CCDS34671.1												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		CCDC146-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000341449.1	5.502261	KEEP		+	10.611418	0.114286	4	31	---	---	---	---	1	0.821525	2	22	0	47	4	31	0	47	2	0	0	0	0	0	0	4	31	0	47	2	TP
CROT	54677	broad.mit.edu	37	7	86998729	86998729	+	Silent	SNP	G	G	T			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr7:86998729G>T	ENST00000331536.3	+	7	770	c.585G>T	c.(583-585)ctG>ctT	p.L195L	CROT_ENST00000442291.1_Silent_p.L195L|CROT_ENST00000419147.2_Silent_p.L223L	NM_021151.3	NP_066974.2	Q9UKG9	OCTC_HUMAN	carnitine O-octanoyltransferase	195		NA		NA	fatty acid beta-oxidation using acyl-CoA oxidase|generation of precursor metabolites and energy|transport	peroxisomal matrix	carnitine O-octanoyltransferase activity		NA	NS(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(4)|lung(21)|ovary(2)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)	37	Esophageal squamous(14;0.0058)|all_lung(186;0.201)|Lung NSC(181;0.203)				L-Carnitine(DB00583)	TTGTAGTGCTGTGTCGAGGCC	0.428	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						213	199	203	NA		NA	NA	7		NA											NA				86998729		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000005469	HGNC:2366	NM_021151	Approved	uc003uit.3	NA	A4D1D6|Q8IUW9|Q9Y6I2	ENST00000331536.3	37	CCDS5604.1												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		CROT-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253485.1	168.81838	KEEP		+	196.318199	0.206395	71	273	---	---	---	---	1	0.9999999	31	67	0	286	75	312	0	286	2	0	0	0	0	0	0	75	312	0	286	2	TP
C9orf131	138724	broad.mit.edu	37	9	35045866	35045866	+	Nonstop_Mutation	SNP	G	G	C			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr9:35045866G>C	ENST00000312292.5	+	2	3287	c.3240G>C	c.(3238-3240)taG>taC	p.*1080Y	C9orf131_ENST00000421362.2_Nonstop_Mutation_p.*1032Y|C9orf131_ENST00000354479.5_Nonstop_Mutation_p.*1007Y	NM_001040410.1|NM_203299.2	NP_001035500.1|NP_976044.2	Q5VYM1	CI131_HUMAN	chromosome 9 open reading frame 131	0		NA		NA					NA	cervix(1)|endometrium(3)|kidney(1)|large_intestine(6)|lung(23)|prostate(2)|skin(2)|stomach(1)	39	all_epithelial(49;0.22)		LUSC - Lung squamous cell carcinoma(32;0.00117)|Lung(28;0.00309)			CTAGTCAGTAGAGAAAAGGCT	0.483	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						110	109	109	NA		NA	NA	9		NA											NA				35045866		2203	4300	6503	SO:0001578	stop_lost			ENSG00000174038	HGNC:31418	NM_203299	Approved	uc003zvw.3	NA	Q86XC6|Q9UF74	ENST00000312292.5	37	CCDS6572.2	.	.	.	.	.	.	.	.	.	.	G	4.538	0.09988	0.08681	.	.	ENSG00000174038	ENST00000421362;ENST00000354479;ENST00000312292;ENST00000435140	.	.	.	2.15	0.15	0.14883	.	.	.	.	.	.	.	.	.	.	.	0.0931	N	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	2.7776	0.05352	0.1666:0.0:0.5594:0.274	.	.	.	.	Y	1032;1007;1080;555	.	.	X	+	3	2	C9orf131	35035866	0	0.05858	0.003	0.11579	0.184	0.23303	-0.415	0.07106	0.039	0.15632	0.447	0.29281	TAG	C9orf131-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052283.5	173.458835	KEEP		+	187.299383	0.244635	57	176	---	---	---	---	1	0.9906562	24	0	0	190	64	186	0	190	2	0	0	0	0	0	0	64	186	0	190	2	TP
C9orf131	138724	broad.mit.edu	37	9	35045873	35045873	+	3'UTR	SNP	G	G	C			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr9:35045873G>C	ENST00000312292.5	+	0	3294				C9orf131_ENST00000421362.2_3'UTR|C9orf131_ENST00000354479.5_3'UTR	NM_001040410.1|NM_203299.2	NP_001035500.1|NP_976044.2	Q5VYM1	CI131_HUMAN	chromosome 9 open reading frame 131	NA		NA		NA					NA	cervix(1)|endometrium(3)|kidney(1)|large_intestine(6)|lung(23)|prostate(2)|skin(2)|stomach(1)	39	all_epithelial(49;0.22)		LUSC - Lung squamous cell carcinoma(32;0.00117)|Lung(28;0.00309)			GTAGAGAAAAGGCTGGTAATA	0.473	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						103	102	102	NA		NA	NA	9		NA											NA				35045873		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000174038	HGNC:31418	NM_203299	Approved	uc003zvw.3	NA	Q86XC6|Q9UF74	ENST00000312292.5	37	CCDS6572.2												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		C9orf131-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052283.5	127.683726	KEEP		+	141.300484	0.238532	52	166	---	---	---	---	1	0.9802111	22	0	0	179	56	172	0	179	2	0	0	0	0	0	0	56	172	0	179	2	TP
GPR107	0	broad.mit.edu	37	9	132848732	132848732	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr9:132848732A>G	ENST00000372406.1	+	7	1105	c.598A>G	c.(598-600)Aat>Gat	p.N200D	GPR107_ENST00000372410.3_Missense_Mutation_p.N200D|GPR107_ENST00000347136.6_Missense_Mutation_p.N200D	NM_001136557.1	NP_001130029.1	Q5VW38	GP107_HUMAN	G protein-coupled receptor 107	200		NA		NA		integral to membrane			NA	endometrium(2)|lung(5)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)	11		Ovarian(14;0.000531)				TGTTCATAATAATGGTGGGGC	0.348	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						195	189	191	NA		NA	NA	9		NA											NA				132848732		2203	4300	6503	SO:0001583	missense			ENSG00000148358	HGNC:17830		Approved	uc004bzd.2	NA	A6NJ53|Q2TB81|Q5JPA3|Q5VW39|Q96T26|Q9H658|Q9HCE8	ENST00000372406.1	37	CCDS48041.1	.	.	.	.	.	.	.	.	.	.	A	9.507	1.104713	0.20632	.	.	ENSG00000148358	ENST00000372406;ENST00000347136;ENST00000372410;ENST00000455412	T;T;T	0.23147	1.92;1.93;1.93	5.56	5.56	0.83823	.	0.451094	0.23799	N	0.044455	T	0.15696	0.0378	N	0.20685	0.6	0.0931	N	1	B;B;B	0.02656	0.0;0.0;0.0	B;B;B	0.06405	0.001;0.002;0.001	T	0.20273	-1.0280	10	0.12103	T	0.63	-7.4326	12.125	0.53913	1.0:0.0:0.0:0.0	.	200;200;200	G5E994;Q5VW38;Q5VW38-2	.;GP107_HUMAN;.	D	200	ENSP00000361483:N200D;ENSP00000336988:N200D;ENSP00000361487:N200D	ENSP00000336988:N200D	N	+	1	0	GPR107	131888553	0.007	0.16637	0.028	0.17463	0.645	0.38454	2.227	0.42972	2.123	0.65237	0.477	0.44152	AAT	GPR107-003	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054643.2	131.779141	KEEP		+	140.966239	0.253012	42	124	---	---	---	---	1	0.972064	11	11	0	176	46	154	0	176	2	0	0	0	0	0	0	46	154	0	176	2	TP
APBB1	322	broad.mit.edu	37	11	6432089	6432089	+	Missense_Mutation	SNP	A	A	C	rs150119080	byFrequency	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr11:6432089A>C	ENST00000389906.2	-	2	588	c.489T>G	c.(487-489)gaT>gaG	p.D163E	APBB1_ENST00000311051.3_Missense_Mutation_p.D163E|APBB1_ENST00000299402.6_Missense_Mutation_p.D163E|APBB1_ENST00000533407.1_Intron	NM_001257325.1	NP_001244254.1	O00213	APBB1_HUMAN	amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65)	163	Glu-rich.	NA		NA	apoptosis|axonogenesis|cell cycle arrest|histone H4 acetylation|negative regulation of cell growth|negative regulation of S phase of mitotic cell cycle|negative regulation of thymidylate synthase biosynthetic process|positive regulation of apoptosis|positive regulation of transcription, DNA-dependent|response to DNA damage stimulus|signal transduction|transcription, DNA-dependent	cytoplasm|growth cone|lamellipodium|nucleus|plasma membrane|synapse	beta-amyloid binding|chromatin binding|histone binding|proline-rich region binding|transcription factor binding		NA	breast(4)|endometrium(3)|kidney(1)|large_intestine(7)|lung(5)|prostate(2)|skin(1)|urinary_tract(1)	24		Medulloblastoma(188;0.00263)|all_neural(188;0.026)|Breast(177;0.029)		Epithelial(150;6.49e-08)|BRCA - Breast invasive adenocarcinoma(625;0.194)		catcatcatcatcctcctcct	0.637	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(147;1810 2556 5672 39622)	NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA	C	GLU/ASP,GLU/ASP	7,4395	9.9+/-24.2	0,7,2194	35	35	35	NA	489,489	-10	0.9	11	dbSNP_134	35	30,8562	17.9+/-57.8	1,28,4267	no	missense,missense	APBB1	NM_001164.2,NM_145689.1	45,45	1,35,6461	CC,CA,AA	NA	0.3492,0.159,0.2847	benign,benign	163/711,163/709	6432089	37,12957	2201	4296	6497	SO:0001583	missense				HGNC:581	NM_001164	Approved	uc001mcy.1	NA	A6NH82|A6NL69|D3DQT2|Q96A93	ENST00000389906.2	37		.	.	.	.	.	.	.	.	.	.	a	0.01	-1.789594	0.00623	0.00159	0.003492	ENSG00000166313	ENST00000299402;ENST00000311051;ENST00000389906	T;T;T	0.12774	2.65;2.65;2.65	5	-10	0.00425	.	0.778993	0.11213	N	0.587490	T	0.02193	0.0068	N	0.02539	-0.55	0.0931	N	1	B	0.02656	0.0	B	0.04013	0.001	T	0.33111	-0.9881	10	0.02654	T	1	-1.3744	0.6288	0.00791	0.1915:0.2414:0.2847:0.2824	.	163	O00213-2	.	E	163	ENSP00000299402:D163E;ENSP00000311912:D163E;ENSP00000374556:D163E	ENSP00000299402:D163E	D	-	3	2	APBB1	6388665	0	0.05858	0.875	0.34327	0.073	0.16967	-3.791	0.00365	-1.499	0.01821	-1.54	0.00911	GAT	APBB1-201	KNOWN	basic	protein_coding	NA	protein_coding		-20.571265	KEEP		-	7.131972	0.026786	3	109	---	---	---	---	1	0.6639154	3	78	0	113	3	118	0	113	2	0	0	0	0	0	0	3	118	0	113	2	TP
USP28	57646	broad.mit.edu	37	11	113688486	113688486	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr11:113688486T>C	ENST00000003302.4	-	13	1425	c.1357A>G	c.(1357-1359)Agt>Ggt	p.S453G	USP28_ENST00000260188.5_Missense_Mutation_p.S453G|USP28_ENST00000537706.1_Missense_Mutation_p.S453G|USP28_ENST00000545540.1_Missense_Mutation_p.S328G|RP11-667M19.10_ENST00000399123.2_RNA|USP28_ENST00000544967.1_Missense_Mutation_p.S161G	NM_020886.2	NP_065937.1	Q96RU2	UBP28_HUMAN	ubiquitin specific peptidase 28	453		NA		NA	cell proliferation|DNA damage checkpoint|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA repair|protein deubiquitination|response to ionizing radiation|ubiquitin-dependent protein catabolic process	nucleolus|nucleoplasm	protein binding|ubiquitin thiolesterase activity|ubiquitin-specific protease activity		NA	breast(4)|cervix(1)|endometrium(2)|kidney(3)|large_intestine(12)|lung(24)|ovary(1)|prostate(5)|skin(4)|upper_aerodigestive_tract(2)|urinary_tract(1)	59		all_cancers(61;3.74e-18)|all_epithelial(67;3.75e-11)|Melanoma(852;1.46e-05)|all_hematologic(158;4.65e-05)|Acute lymphoblastic leukemia(157;0.000967)|Breast(348;0.0101)|Prostate(24;0.0153)|all_neural(223;0.0281)|Medulloblastoma(222;0.0425)		BRCA - Breast invasive adenocarcinoma(274;3.93e-06)|Epithelial(105;0.000122)|all cancers(92;0.00104)		GGTTTTGTACTAGCAAATTCA	0.463	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Melanoma(4;162 555 7664)|GBM(79;500 2010 17506)|Esophageal Squamous(9;463 924 15765)	NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						157	142	147	NA		NA	NA	11		NA											NA				113688486		2201	4296	6497	SO:0001583	missense			ENSG00000048028	HGNC:12625		Approved	uc001poh.3	NA	B0YJC0|B0YJC1|Q9P213	ENST00000003302.4	37	CCDS31680.1	.	.	.	.	.	.	.	.	.	.	T	19.57	3.85195	0.71719	.	.	ENSG00000048028	ENST00000003302;ENST00000260188;ENST00000544967;ENST00000545540;ENST00000537706	T;T;T;T;T	0.49720	1.37;1.37;0.77;1.38;1.78	5.48	5.48	0.80851	Peptidase C19, ubiquitin carboxyl-terminal hydrolase 2 (2);	0.092076	0.85682	D	0.000000	T	0.51753	0.1693	M	0.76170	2.325	0.37894	D	0.930813	P;P;P;P	0.43542	0.507;0.81;0.763;0.649	B;B;B;B	0.43155	0.338;0.41;0.403;0.228	T	0.63161	-0.6699	10	0.62326	D	0.03	-20.3523	11.6313	0.51175	0.0:0.0707:0.0:0.9293	.	328;453;453;161	B4E3L3;Q6NZX9;Q96RU2;G3V1N5	.;.;UBP28_HUMAN;.	G	453;453;161;328;453	ENSP00000003302:S453G;ENSP00000260188:S453G;ENSP00000442431:S161G;ENSP00000444991:S328G;ENSP00000445743:S453G	ENSP00000003302:S453G	S	-	1	0	USP28	113193696	1	0.71417	1	0.80357	0.994	0.84299	4.13	0.57964	2.307	0.77673	0.528	0.53228	AGT	USP28-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000398789.1	203.539577	KEEP		-	207.772304	0.340426	64	124	---	---	---	---	1	0.9988629	13	11	1	161	66	131	1	161	2	0	0	0	0	0	0	66	131	1	161	2	TP
AACS	65985	broad.mit.edu	37	12	125599073	125599073	+	Silent	SNP	C	C	A			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr12:125599073C>A	ENST00000316519.6	+	9	1172	c.966C>A	c.(964-966)acC>acA	p.T322T	AACS_ENST00000261686.6_Silent_p.T322T|AACS_ENST00000316543.10_5'UTR	NM_023928.3	NP_076417.2	Q86V21	AACS_HUMAN	acetoacetyl-CoA synthetase	322		NA		NA	fatty acid metabolic process	cytosol	acetoacetate-CoA ligase activity|ATP binding		NA	breast(1)|central_nervous_system(1)|cervix(1)|large_intestine(4)|liver(1)|lung(16)|ovary(1)|stomach(1)	26	all_neural(191;0.101)|Medulloblastoma(191;0.163)			OV - Ovarian serous cystadenocarcinoma(86;9.82e-05)|Epithelial(86;0.000642)|all cancers(50;0.00843)		GCAACATGACCAGCAGTGACA	0.607	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						112	87	95	NA		NA	NA	12		NA											NA				125599073		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000081760	HGNC:21298	NM_023928	Approved	uc001uhc.3	NA	Q49AB9|Q49AC3|Q658Q8|Q8IWD2|Q8NEW5|Q9BSJ9|Q9H829|Q9HA19	ENST00000316519.6	37	CCDS9263.1												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		AACS-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400202.1	43.904279	KEEP		+	48.721311	0.236842	18	58	---	---	---	---	1	0.9506378	8	11	0	81	20	68	0	81	2	0	0	0	0	0	0	20	68	0	81	2	TP
IPO5	3843	broad.mit.edu	37	13	98666352	98666352	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr13:98666352C>T	ENST00000261574.5	+	22	2443	c.2263C>T	c.(2263-2265)Cgt>Tgt	p.R755C	IPO5_ENST00000539640.1_Missense_Mutation_p.R612C|IPO5_ENST00000490680.1_Missense_Mutation_p.R737C	NM_002271.4	NP_002262.3	O00410	IPO5_HUMAN	importin 5	737		NA		NA	interspecies interaction between organisms|NLS-bearing substrate import into nucleus|ribosomal protein import into nucleus	cytoplasm|nuclear pore|nucleolus	GTPase inhibitor activity|protein transporter activity|Ran GTPase binding		NA	breast(2)|endometrium(2)|large_intestine(8)|lung(8)|ovary(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(2)	27						TGCAAGAGTCCGTGGTCCTGA	0.438	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						148	143	145	NA		NA	NA	13		NA											NA				98666352		2203	4300	6503	SO:0001583	missense			ENSG00000065150	HGNC:6402	NM_002271	Approved	uc001vne.3	NA	B4DZA0|O15257|Q5T578|Q86XC7	ENST00000261574.5	37	CCDS31999.1	.	.	.	.	.	.	.	.	.	.	C	33	5.283094	0.95489	.	.	ENSG00000065150	ENST00000261574;ENST00000357602;ENST00000490680;ENST00000539640	T;T;T;T	0.68181	-0.31;-0.31;-0.31;-0.31	5.75	5.75	0.90469	.	0.000000	0.85682	D	0.000000	T	0.80607	0.4655	M	0.63843	1.955	0.80722	D	1	D	0.76494	0.999	D	0.66847	0.947	T	0.81348	-0.0973	10	0.87932	D	0	0.4589	19.9311	0.97118	0.0:1.0:0.0:0.0	.	755	O00410-3	.	C	755;737;737;612	ENSP00000261574:R755C;ENSP00000350219:R737C;ENSP00000418393:R737C;ENSP00000445126:R612C	ENSP00000261574:R755C	R	+	1	0	IPO5	97464353	1	0.71417	0.439	0.26833	0.996	0.88848	7.554	0.82212	2.721	0.93114	0.655	0.94253	CGT	IPO5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000045533.2	23.785478	KEEP		+	46.225154	0.116129	18	137	---	---	---	---	1	0.9999241	27	101	0	126	18	140	0	126	2	0	0	0	0	0	0	18	140	0	126	2	TP
SLC7A7	9056	broad.mit.edu	37	14	23245049	23245049	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr14:23245049C>T	ENST00000397532.3	-	6	1516	c.991G>A	c.(991-993)Gct>Act	p.A331T	SLC7A7_ENST00000554517.1_Missense_Mutation_p.A65T|SLC7A7_ENST00000554061.1_5'UTR|SLC7A7_ENST00000397528.4_Missense_Mutation_p.A331T|SLC7A7_ENST00000397529.2_Missense_Mutation_p.A331T|SLC7A7_ENST00000285850.7_Missense_Mutation_p.A331T|SLC7A7_ENST00000555702.1_Missense_Mutation_p.A331T			Q9UM01	YLAT1_HUMAN	solute carrier family 7 (amino acid transporter light chain, y+L system), member 7	331		NA		NA	blood coagulation|cellular amino acid metabolic process|ion transport|leukocyte migration|protein complex assembly	basolateral plasma membrane|integral to plasma membrane	amino acid transmembrane transporter activity		NA	breast(2)|central_nervous_system(2)|endometrium(1)|kidney(1)|large_intestine(3)|lung(8)|ovary(1)|skin(2)	20	all_cancers(95;8.44e-05)			GBM - Glioblastoma multiforme(265;0.00741)		TACCTAGAAGCAGCCACAATG	0.428	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						145	149	148	NA		NA	NA	14		NA											NA				23245049		2203	4300	6503	SO:0001583	missense			ENSG00000155465	HGNC:11065		Approved	uc001wgs.4	NA	B2RAU0|D3DS26|O95984|Q53XC1|Q86U07|Q9P2V5	ENST00000397532.3	37	CCDS9574.1	.	.	.	.	.	.	.	.	.	.	C	31	5.076719	0.94	.	.	ENSG00000155465	ENST00000285850;ENST00000555702;ENST00000397532;ENST00000404278;ENST00000397529;ENST00000397528;ENST00000554517	D;D;D;D;D;D	0.90385	-2.66;-2.66;-2.66;-2.66;-2.66;-2.66	6.08	6.08	0.98989	Amino acid permease domain (1);	0.106801	0.64402	D	0.000006	D	0.93641	0.7969	L	0.58302	1.8	0.58432	D	0.999994	P	0.46142	0.873	P	0.56088	0.791	D	0.93457	0.6807	10	0.87932	D	0	.	19.4349	0.94788	0.0:1.0:0.0:0.0	.	331	Q9UM01	YLAT1_HUMAN	T	331;331;331;304;331;331;65	ENSP00000285850:A331T;ENSP00000451881:A331T;ENSP00000380666:A331T;ENSP00000380663:A331T;ENSP00000380662:A331T;ENSP00000452083:A65T	ENSP00000285850:A331T	A	-	1	0	SLC7A7	22314889	0.999	0.42202	1	0.80357	0.998	0.95712	1.828	0.39111	2.894	0.99253	0.655	0.94253	GCT	SLC7A7-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000071636.3	191.860164	KEEP		-	192.906144	0.414634	68	96	---	---	---	---	1	1	15	92	0	242	88	128	0	242	2	0	0	0	0	0	0	88	128	0	242	2	TP
NFKBIA	4792	broad.mit.edu	37	14	35871759	35871759	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr14:35871759C>A	ENST00000216797.5	-	5	848	c.747G>T	c.(745-747)caG>caT	p.Q249H	NFKBIA_ENST00000557389.1_Missense_Mutation_p.Q159H|NFKBIA_ENST00000557100.1_5'UTR|NFKBIA_ENST00000557140.1_Intron	NM_020529.2	NP_065390.1	P25963	IKBA_HUMAN	nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha	249		NA		NA	anti-apoptosis|apoptosis|cellular response to cold|cytoplasmic sequestering of NF-kappaB|innate immune response|interspecies interaction between organisms|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|negative regulation of DNA binding|negative regulation of lipid storage|negative regulation of macrophage derived foam cell differentiation|negative regulation of NF-kappaB transcription factor activity|nerve growth factor receptor signaling pathway|positive regulation of cellular protein metabolic process|positive regulation of cholesterol efflux|positive regulation of NF-kappaB transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|T cell receptor signaling pathway|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway	cytosol|I-kappaB/NF-kappaB complex|nucleus|plasma membrane	identical protein binding|NF-kappaB binding|nuclear localization sequence binding|ubiquitin protein ligase binding		NA	breast(3)|endometrium(1)|large_intestine(2)|liver(1)	7	Breast(36;0.0484)|Hepatocellular(127;0.158)		Lung(238;9.25e-06)|LUAD - Lung adenocarcinoma(48;1.53e-05)|Epithelial(34;0.00314)|all cancers(34;0.00891)	GBM - Glioblastoma multiforme(112;0.0222)		GAGAATAGCCCTGGTAGGTAA	0.577	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						106	102	103	NA		NA	NA	14		NA											NA				35871759		2203	4300	6503	SO:0001583	missense			ENSG00000100906	HGNC:7797	NM_020529	Approved	uc001wtf.4	NA	B2R8L6	ENST00000216797.5	37	CCDS9656.1	.	.	.	.	.	.	.	.	.	.	C	17.5	3.406326	0.62288	.	.	ENSG00000100906	ENST00000216797;ENST00000557389	T;T	0.35973	1.28;1.28	5.32	-0.489	0.12052	Ankyrin repeat-containing domain (3);	.	.	.	.	T	0.38825	0.1055	L	0.57536	1.79	0.52099	D	0.999944	D	0.58268	0.982	P	0.50162	0.633	T	0.20405	-1.0276	9	0.37606	T	0.19	-2.3947	10.0673	0.42311	0.0:0.5647:0.0:0.4353	.	249	P25963	IKBA_HUMAN	H	249;159	ENSP00000216797:Q249H;ENSP00000450514:Q159H	ENSP00000216797:Q249H	Q	-	3	2	NFKBIA	34941510	0.97	0.3359	0.991	0.4774	0.991	0.79684	0.102	0.15272	-0.324	0.08589	0.655	0.94253	CAG	NFKBIA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000276683.1	-20.861796	KEEP		-	27.9503	0.058577	14	225	---	---	---	---	1	1	169	1286	0	249	16	250	0	249	2	0	0	0	0	0	0	16	250	0	249	2	TP
FOXN3	1112	broad.mit.edu	37	14	89628671	89628671	+	3'UTR	SNP	T	T	C			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr14:89628671T>C	ENST00000345097.4	-	0	1676				FOXN3_ENST00000261302.5_3'UTR|FOXN3_ENST00000557258.1_3'UTR	NM_001085471.1	NP_001078940.1	O00409	FOXN3_HUMAN	forkhead box N3	NA		NA		NA	DNA damage checkpoint|embryo development|G2 phase of mitotic cell cycle|negative regulation of transcription, DNA-dependent|pattern specification process|regulation of sequence-specific DNA binding transcription factor activity|tissue development	transcription factor complex	DNA bending activity|double-stranded DNA binding|promoter binding|protein C-terminus binding|sequence-specific DNA binding|sequence-specific enhancer binding RNA polymerase II transcription factor activity|specific RNA polymerase II transcription factor activity|specific transcriptional repressor activity|transcription activator activity|transcription factor binding		NA	endometrium(4)|large_intestine(4)|lung(5)|ovary(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	18						agaaaaaaaaTTGCTGATATT	0.308	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000053254	HGNC:1928	NM_005197	Approved	uc001xxo.4	NA	Q96II7|Q9UIE7	ENST00000345097.4	37	CCDS41977.1												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		FOXN3-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000410902.2	33.54638	KEEP		-	33.764634	0.4	10	15	---	---	---	---	1	0.9305578	8	2	0	34	10	15	0	34	2	0	0	0	0	0	0	10	15	0	34	2	TP
DNAH3	55567	broad.mit.edu	37	16	20975342	20975342	+	Silent	SNP	G	G	A	rs142743875	byFrequency|by1000genomes	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr16:20975342G>A	ENST00000261383.3	-	53	9863	c.9864C>T	c.(9862-9864)gaC>gaT	p.D3288D	DNAH3_ENST00000415178.1_3'UTR	NM_017539.1	NP_060009.1	Q8TD57	DYH3_HUMAN	dynein, axonemal, heavy chain 3	3288		NA		NA	ciliary or flagellar motility|microtubule-based movement	axonemal dynein complex|cilium axoneme|cytoplasm|microtubule	ATP binding|microtubule motor activity		NA	NS(3)|autonomic_ganglia(1)|breast(12)|central_nervous_system(3)|cervix(2)|endometrium(15)|haematopoietic_and_lymphoid_tissue(4)|kidney(10)|large_intestine(42)|liver(2)|lung(57)|ovary(14)|pancreas(1)|prostate(7)|skin(11)|stomach(5)|upper_aerodigestive_tract(7)|urinary_tract(6)	202				GBM - Glioblastoma multiforme(48;0.207)		TCCGAGTCTCGTCAATCTGCG	0.498	NA	NA	NA			NA	NA	NA		NA	NA	NA	G	1	5e-04	0.002	NA	2184	NA	1	,	,	NA	3e-04	NA	NA	NA	5e-04	1	LOWCOV,EXOME	NA	NA	4e-04	SNP		NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA	G		12,4390	19.1+/-41.9	0,12,2189	125	126	125	NA	9864	-5.4	0	16	dbSNP_134	125	0,8600		0,0,4300	no	coding-synonymous	DNAH3	NM_017539.1		0,12,6489	AA,AG,GG	NA	0.0,0.2726,0.0923		3288/4117	20975342	12,12990	2201	4300	6501	SO:0001819	synonymous_variant			ENSG00000158486	HGNC:2949	NM_017539	Approved	uc010vbe.2	NA	O00437|O15437|O43326|Q3C0H2|Q8WUP9|Q9UEM3|Q9UEM5|Q9UG35	ENST00000261383.3	37	CCDS10594.1												NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		DNAH3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207361.1	128.384069	KEEP		-	136.699074	0.274725	50	132	---	---	---	---	1	0.5653056	7	0	0	167	60	176	0	167	2	0	0	0	0	0	0	60	176	0	167	2	TP
KIAA0556	23247	broad.mit.edu	37	16	27761189	27761189	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr16:27761189G>A	ENST00000261588.4	+	16	2927	c.2908G>A	c.(2908-2910)Gtc>Atc	p.V970I		NM_015202.2	NP_056017.2	O60303	K0556_HUMAN	KIAA0556	970		NA		NA					NA	breast(4)|endometrium(7)|kidney(8)|large_intestine(17)|lung(24)|ovary(5)|prostate(3)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(3)	76						TAAAATCCCCGTCTTGCCTTA	0.557	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA	G	ILE/VAL	0,4394		0,0,2197	41	41	41	NA	2908	5	0.2	16		41	2,8598	2.2+/-6.3	0,2,4298	no	missense	KIAA0556	NM_015202.2	29	0,2,6495	AA,AG,GG	NA	0.0233,0.0,0.0154	probably-damaging	970/1619	27761189	2,12992	2197	4300	6497	SO:0001583	missense			ENSG00000047578	HGNC:29068	NM_015202	Approved	uc002dow.3	NA	A7E2C2	ENST00000261588.4	37	CCDS32415.1	.	.	.	.	.	.	.	.	.	.	G	17.08	3.29858	0.60195	0.0	2.33E-4	ENSG00000047578	ENST00000261588	T	0.13538	2.58	4.98	4.98	0.66077	.	0.000000	0.85682	D	0.000000	T	0.29620	0.0739	L	0.54323	1.7	0.39599	D	0.969709	D	0.65815	0.995	P	0.62435	0.902	T	0.01541	-1.1329	10	0.52906	T	0.07	-22.0539	14.725	0.69339	0.0:0.1456:0.8544:0.0	.	970	O60303	K0556_HUMAN	I	970	ENSP00000261588:V970I	ENSP00000261588:V970I	V	+	1	0	KIAA0556	27668690	1	0.71417	0.242	0.2417	0.223	0.24884	7.713	0.84693	2.462	0.83206	0.655	0.94253	GTC	KIAA0556-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000433724.1	72.027319	KEEP		+	73.701259	0.342105	26	50	---	---	---	---	1	0.9958261	7	14	0	65	27	53	0	65	2	0	0	0	0	0	0	27	53	0	65	2	TP
SMCR8	140775	broad.mit.edu	37	17	18219935	18219935	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr17:18219935G>A	ENST00000406438.3	+	1	1312	c.832G>A	c.(832-834)Gcc>Acc	p.A278T	TOP3A_ENST00000321105.5_5'Flank|TOP3A_ENST00000542570.1_5'Flank|TOP3A_ENST00000582230.1_5'Flank	NM_144775.2	NP_658988.2	Q8TEV9	SMCR8_HUMAN	Smith-Magenis syndrome chromosome region, candidate 8	278		NA		NA					NA	breast(1)|central_nervous_system(1)|endometrium(3)|kidney(4)|large_intestine(1)|lung(7)|skin(2)|stomach(1)|upper_aerodigestive_tract(1)	21						CCAGGATCAGGCCAGCCAGGC	0.517	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						77	63	68	NA		NA	NA	17		NA											NA				18219935		2203	4300	6503	SO:0001583	missense			ENSG00000176994	HGNC:17921	NM_144775	Approved	uc002gsy.4	NA	A5PKZ5|Q3ZCN0|Q6PJL3	ENST00000406438.3	37	CCDS11195.2	.	.	.	.	.	.	.	.	.	.	G	1.15	-0.647069	0.03506	.	.	ENSG00000176994	ENST00000406438	T	0.22743	1.94	6.03	4.03	0.46877	.	0.620599	0.16795	N	0.199223	T	0.16642	0.0400	L	0.40543	1.245	0.41441	D	0.987921	P	0.43352	0.804	B	0.37387	0.248	T	0.03231	-1.1058	10	0.14252	T	0.57	-31.7773	13.9718	0.64245	0.0:0.1299:0.7625:0.1076	.	278	Q8TEV9	SMCR8_HUMAN	T	278	ENSP00000385025:A278T	ENSP00000385025:A278T	A	+	1	0	SMCR8	18160660	0.018	0.18449	0.805	0.32314	0.319	0.28217	0.595	0.24029	0.854	0.35336	0.655	0.94253	GCC	SMCR8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000132065.2	53.309419	KEEP		+	57.961666	0.255814	22	64	---	---	---	---	1	0.4387604	6	0	0	69	22	68	0	69	2	0	0	0	0	0	0	22	68	0	69	2	TP
RP11-798G7.5	0	broad.mit.edu	37	17	43587569	43587569	+	RNA	SNP	G	G	C	rs149697015	by1000genomes	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr17:43587569G>C	ENST00000253803.2	+	0	267				LRRC37A4P_ENST00000579913.1_RNA						NA		NA		NA					NA		NA						aactccgtctgaaaagaaaag	0.443	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA										NA		ENST00000253803.2	37													NA	NA	NA								NA	NA	NA												NA		NA																															NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		RP11-798G7.5-201	KNOWN	basic	antisense	NA	antisense		-17.169603	KEEP		+	7.081568	0.03	3	97	---	---	---	---	1	0.04941533	15	5	1	66	3	103	1	66	3	0	0	0	0	0	0	3	103	1	66	2	TP
DUS1L	64118	broad.mit.edu	37	17	80020801	80020801	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr17:80020801C>T	ENST00000354321.7	-	4	931	c.446G>A	c.(445-447)cGt>cAt	p.R149H	DUS1L_ENST00000306796.5_Missense_Mutation_p.R149H			Q6P1R4	DUS1L_HUMAN	dihydrouridine synthase 1-like (S. cerevisiae)	149		NA		NA	tRNA processing		flavin adenine dinucleotide binding|tRNA dihydrouridine synthase activity		NA	breast(1)|endometrium(1)|lung(2)|ovary(1)|skin(1)	6	all_neural(118;0.0878)|Ovarian(332;0.227)|all_lung(278;0.246)		BRCA - Breast invasive adenocarcinoma(99;0.0114)|OV - Ovarian serous cystadenocarcinoma(97;0.0211)			CGGGAAGACACGGATTTTGCA	0.602	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						65	63	64	NA		NA	NA	17		NA											NA				80020801		2202	4300	6502	SO:0001583	missense				HGNC:30086	NM_022156	Approved	uc002kdr.4	NA	A6NHV4|Q96AI3	ENST00000354321.7	37	CCDS32775.1	.	.	.	.	.	.	.	.	.	.	C	16.99	3.274227	0.59649	.	.	ENSG00000169718	ENST00000354321;ENST00000306796;ENST00000542088;ENST00000538833	T;T;T	0.49432	0.78;0.78;0.78	3.61	3.61	0.41365	Aldolase-type TIM barrel (1);	0.000000	0.85682	D	0.000000	T	0.81413	0.4817	H	0.99225	4.475	0.80722	D	1	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.91635	0.987;0.999;0.998	D	0.89996	0.4111	10	0.87932	D	0	-13.6386	15.4443	0.75216	0.0:1.0:0.0:0.0	.	22;149;18	B4DPG7;Q6P1R4;Q9BTJ3	.;DUS1L_HUMAN;.	H	149;149;22;17	ENSP00000346280:R149H;ENSP00000303515:R149H;ENSP00000445110:R17H	ENSP00000303515:R149H	R	-	2	0	DUS1L	77614090	1	0.71417	0.996	0.52242	0.996	0.88848	7.219	0.78	1.851	0.53745	0.591	0.81541	CGT	DUS1L-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000442347.1	89.780921	KEEP		-	97.026415	0.257353	35	101	---	---	---	---	1	1	97	150	0	119	39	113	0	119	2	0	0	0	0	0	0	39	113	0	119	2	TP
DSEL	92126	broad.mit.edu	37	18	65181103	65181103	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-27-1832-Tumor-SM-1QXM9	GBM-TCGA-27-1832-Normal-SM-1QXM3	g.chr18:65181103T>C	ENST00000310045.7	-	2	2246	c.773A>G	c.(772-774)aAt>aGt	p.N258S	CTD-2541J13.2_ENST00000581951.1_RNA|RP11-638L3.1_ENST00000583687.1_lincRNA|CTD-2541J13.2_ENST00000583493.1_RNA	NM_032160.2	NP_115536.1	Q8IZU8	DSEL_HUMAN	dermatan sulfate epimerase-like	248		NA		NA		integral to membrane	isomerase activity|sulfotransferase activity		NA	NS(3)|breast(1)|central_nervous_system(1)|cervix(1)|endometrium(3)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(25)|lung(23)|ovary(4)|pancreas(1)|prostate(2)|skin(3)|stomach(1)|upper_aerodigestive_tract(2)	74		Esophageal squamous(42;0.129)				TTTCCATATATTTGCTTTAGA	0.418	NA	NA	NA			NA	NA	NA		NA	NA	NA		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			NA			NA	NA		NA		NA		0			NA	NA	NA	NA	NA						114	110	112	NA		NA	NA	18		NA											NA				65181103		2203	4300	6503	SO:0001583	missense			ENSG00000171451	HGNC:18144	NM_032160	Approved	uc002lke.1	NA	Q17RH1|Q6P5Z3	ENST00000310045.7	37	CCDS11995.1	.	.	.	.	.	.	.	.	.	.	T	6.829	0.522111	0.13066	.	.	ENSG00000171451	ENST00000310045;ENST00000397964	T	0.22539	1.95	4.95	2.29	0.2861	.	0.391586	0.26258	U	0.025409	T	0.14098	0.0341	L	0.36672	1.1	0.0931	N	1	B	0.17038	0.02	B	0.14578	0.011	T	0.29941	-0.9995	10	0.09338	T	0.73	.	11.4285	0.50025	0.0:0.0:0.2862:0.7138	.	248	Q8IZU8	DSEL_HUMAN	S	258;248	ENSP00000310565:N258S	ENSP00000310565:N258S	N	-	2	0	DSEL	63332083	0.988	0.35896	0.094	0.20943	0.94	0.58332	2.965	0.492	0.819	0.34492	0.454	0.30748	AAT	DSEL-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256221.1	214.343641	KEEP		-	219.960789	0.321608	64	135	---	---	---	---	1	0.2545972	3	0	0	207	77	158	0	207	2	0	0	0	0	0	0	77	158	0	207	2	TP
